Skip to content
healthcare.dev
Get a free key

LAMIVUDINE AND ZIDOVUDINE

NDC 72865-144, lamivudine and zidovudine, tablet, film coated, from XLCare Pharmaceuticals, Inc.

Product NDC
72865-144
Status
Listed
Labeler
XLCare Pharmaceuticals, Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203259
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72865-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1
  • ZIDOVUDINE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
72865-144-607286501446060 TABLET, FILM COATED in 1 BOTTLE (72865-144-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/55520835-0f24-4e52-af8c-d65841ccaba7

Use it

Look up 72865-144 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72865-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72865-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.